Purple Biotech Ltd.
Develops cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
Description
Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-09-13 16:11 |
to Present Overview of Ongoing Phase 1b/2 Clinical Trial of CM24
for Treatment…
|
English | 4.3 MB | ||
| 2021-09-13 16:11 |
to Present Overview of Ongoing Phase 1b/2 Clinical Trial of CM24
for Treatment…
|
English | 36.5 KB | ||
| 2021-08-05 17:43 |
6K: Provides Corporate Update and Reports First Half 2021 Financial Results
|
English | 214.4 KB | ||
| 2021-08-05 17:43 |
6K: Provides Corporate Update and Reports First Half 2021 Financial Results
|
English | 36.7 KB | ||
| 2021-06-10 10:30 |
6K:Sales Agreement
|
English | 538.7 KB | ||
| 2021-06-10 10:30 |
6K:Sales Agreement
|
English | 36.8 KB | ||
| 2021-06-10 10:26 |
PROSPECTUS SUPPLEMENT
(to Prospectus dated December 13, 2019)
|
English | 665.7 KB | ||
| 2021-06-10 10:26 |
PROSPECTUS SUPPLEMENT
(to Prospectus dated December 13, 2019)
|
English | 36.6 KB | ||
| 2021-06-10 10:23 |
6K: Financial results for the three-month period ended March 31, 2021
|
English | 155.5 KB | ||
| 2021-06-10 10:23 |
6K: Financial results for the three-month period ended March 31, 2021
|
English | 36.5 KB | ||
| 2021-06-06 10:29 |
Presents New Clinical Data from NT219 at the 2021 ASCO Annual Meeting
|
English | 3.9 MB | ||
| 2021-06-06 10:29 |
Presents New Clinical Data from NT219 at the 2021 ASCO Annual Meeting
|
English | 36.3 KB | ||
| 2021-05-26 16:50 |
PR:Purple Biotech to Present at the Jefferies Virtual Healthcare Conference
|
English | 176.7 KB | ||
| 2021-05-26 16:50 |
PR:Purple Biotech to Present at the Jefferies Virtual Healthcare Conference
|
English | 36.2 KB | ||
| 2021-05-20 16:10 |
6K: Purple Biotech to Present New Clinical Data from NT219 at the 2021 ASCO Ann…
|
English | 150.6 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Purple Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
